← Merck & Co., Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $39.8b | $40.1b | $42.3b | $46.8b | $48.0b | $48.7b | $59.3b | $60.1b | $64.2b | $65.0b | |
| Cost of Revenue | $13.9b | $12.8b | $13.5b | $14.1b | $15.5b | $13.6b | $17.4b | $16.1b | $15.2b | $16.4b | |
| Cost of sales | $14.0b | $12.9b | $13.5b | $14.1b | $15.5b | $13.6b | $17.4b | $16.1b | $15.2b | $16.4b | |
| Gross Profit (Calculated) | $25.9b | $27.3b | $28.8b | $32.7b | $32.5b | $35.1b | $41.9b | $44.0b | $49.0b | $48.6b | |
| Research and development | $10.1b | $10.2b | $9.8b | $9.9b | $13.6b | $12.2b | $13.5b | $30.5b | $17.9b | $15.8b | |
| Selling, general and administrative | $9.8b | $9.8b | $10.1b | $10.6b | $10.5b | $9.6b | $10.0b | $10.5b | $10.8b | $10.7b | |
| Operating expenses: | |||||||||||
| Additional Financial Items | |||||||||||
| Amortization of Intangible Assets | $3.8b | $3.2b | $2.9b | $2.0b | $1.9b | $1.6b | $2.1b | $2.0b | $2.4b | $2.8b | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | — | — | — | $1.4b | ($1.0b) | — | — | — | |
| Foreign Currency Transaction Gain (Loss), Realized | $0 | $0 | — | — | — | — | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($174.0m) | $11.0m | ($145.0m) | ($187.0m) | ($145.0m) | ($297.0m) | ($237.0m) | ($370.0m) | ($227.0m) | ($323.0m) | |
| Gain (Loss) Related to Litigation Settlement | ($625.0m) | $0 | $0 | — | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | $47.0m | $38.0m | $144.0m | $162.0m | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | $518.0m | $3.5b | $3.7b | $439.0m | ($3.5b) | $1.9b | $1.0b | ($15.6b) | ($1.8b) | ($4.9b) | |
| Income (Loss) from Continuing Operations, Per Basic Share | $1 | $1 | $2 | $4 | $3 | $5 | $6 | $0 | $7 | $7 | |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | — | — | — | $5 | $6 | $0 | — | — | |
| Income (Loss) from Equity Method Investments | $86.0m | $42.0m | — | — | — | — | — | — | — | — | |
| Taxes on Income | $718.0m | $4.1b | $2.5b | $1.7b | $1.7b | $1.5b | $1.9b | $1.5b | $2.8b | $2.8b | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $4.7b | $6.5b | $8.7b | $11.5b | $8.8b | $13.9b | $16.4b | $1.9b | $19.9b | $21.1b | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | $12.3b | $14.5b | $365.0m | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $21.0m | $24.0m | $27.0m | $66.0m | $15.0m | $12.4b | $14.5b | $377.0m | $16.0m | $9.0m | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | $704.0m | $0 | $0 | — | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $21.0m | $24.0m | $27.0m | $66.0m | $15.0m | $707.0m | $7.0m | $12.0m | $16.0m | $9.0m | |
| Income Before Taxes | $4.7b | $6.5b | $8.7b | $11.5b | $8.8b | $13.9b | $16.4b | $1.9b | $19.9b | $21.1b | |
| Net Income (Loss) Attributable to Parent | $3.9b | $2.4b | $6.2b | $9.8b | $7.1b | $13.0b | $14.5b | $365.0m | $17.1b | $18.3b | |
| Net Income (Loss) Available to Common Stockholders, Basic | $3.9b | $2.4b | $6.2b | $9.8b | $7.1b | $13.0b | $14.5b | $365.0m | $17.1b | $18.3b | |
| Less: Net Income Attributable to Noncontrolling Interests | $21.0m | $24.0m | ($27.0m) | ($66.0m) | $15.0m | $13.0m | $7.0m | $12.0m | $16.0m | $9.0m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $21.0m | $24.0m | ($27.0m) | ($66.0m) | $15.0m | $16.0m | $7.0m | $12.0m | $16.0m | $9.0m | |
| Common Stock, Dividends, Per Share, Declared | $1.77 | $1.80 | $1.90 | $2.16 | $2.37 | $2.64 | $2.80 | $2.96 | $3.12 | $3.28 | |
| Earnings Per Share, Basic | $1.35 | $0.84 | $2.23 | $3.66 | $2.66 | $5.16 | $5.73 | $0.14 | $6.76 | $7.30 | |
| Earnings Per Share, Diluted | $1.35 | $0.83 | $2.21 | $3.64 | $2.65 | $5.14 | $5.71 | $0.14 | $6.74 | $7.28 | |
| Weighted Average Number of Shares Outstanding, Basic | 2.9b | 2.9b | 2.8b | 2.7b | 2.7b | 2.5b | 2.5b | 2.5b | 2.5b | 2.5b | |
| Weighted Average Number of Shares Outstanding, Diluted | 2.9b | 2.9b | 2.8b | 2.7b | 2.7b | 2.5b | 2.5b | 2.5b | 2.5b | 2.5b | |
| Current Income Tax Expense (Benefit) | $2.2b | $6.7b | $3.0b | $2.2b | $2.4b | $1.3b | $3.5b | $3.4b | $4.1b | $4.5b | |
| Interest Expense | $693.0m | $754.0m | $772.0m | $893.0m | $831.0m | $806.0m | $962.0m | $1.1b | — | — | |
| Interest Expense (non-operating) | — | — | — | — | — | — | — | — | $1.3b | $1.4b | |
| Other (income) expense, net | $720.0m | $12.0m | ($402.0m) | $139.0m | ($886.0m) | ($1.3b) | $1.5b | $466.0m | ($24.0m) | $151.0m | |
| Other Nonoperating Income (Expense) | ($720.0m) | ($12.0m) | $402.0m | ($139.0m) | $886.0m | $1.3b | ($1.5b) | ($466.0m) | $24.0m | ($151.0m) | |
| Research and Development Expense | $10.1b | $10.2b | $9.8b | $9.9b | $13.6b | $12.2b | $13.5b | $30.5b | $17.9b | $15.8b | |
| Restructuring and Related Cost, Incurred Cost | $1.1b | $927.0m | $658.0m | $927.0m | $883.0m | $868.0m | $666.0m | $933.0m | $888.0m | $2.6b | |
| Restructuring costs | $651.0m | $776.0m | $632.0m | $638.0m | $578.0m | $661.0m | $337.0m | $599.0m | $309.0m | $889.0m | |
| Selling, General and Administrative Expense | $9.8b | $9.8b | $10.1b | $10.6b | $10.5b | $9.6b | $10.0b | $10.5b | $10.8b | $10.7b | |
| Income Tax Expense (Benefit) | $718.0m | $4.1b | $2.5b | $1.7b | $1.7b | $1.5b | $1.9b | $1.5b | $2.8b | $2.8b | |
| Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component | — | — | ($512.0m) | ($545.0m) | ($339.0m) | ($212.0m) | ($279.0m) | ($498.0m) | ($633.0m) | ($615.0m) | |
| Total costs, expenses and other | $35.1b | $33.6b | $33.6b | $35.4b | $39.2b | $34.8b | $42.8b | $58.2b | $44.2b | $43.9b |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.